Tauriga Sciences Inc (TAUG) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
4 NANCY COURT, SUITE 4 WAPPINGERS FALLS, NY 12590 |
| State of Incorp. | FL |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 50 | 5 | 386 | 12 | |||
| Cash and cash equivalents | 50 | 5 | 386 | 12 | |||
| Receivables | 32 | (22) | 1 | ||||
| Inventory, net of allowances, customer advances and progress billings | 201 | 129 | 11 | ||||
| Inventory | 201 | 129 | 11 | ||||
| Disposal group, including discontinued operation | 1 | ||||||
| Other undisclosed current assets | 2,113 | 495 | 550 | 673 | |||
| Total current assets: | 2,397 | 608 | 948 | 686 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 64 | 22 | ✕ | ✕ | |||
| Property, plant and equipment | 12 | 13 | 13 | 2 | |||
| Other undisclosed noncurrent assets | 16 | ||||||
| Total noncurrent assets: | 92 | 36 | 13 | 2 | |||
| TOTAL ASSETS: | 2,489 | 643 | 961 | 689 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 474 | 162 | 65 | 64 | |||
| Accounts payable | 391 | 76 | 35 | 30 | |||
| Accrued liabilities | 68 | 47 | |||||
| Interest and dividends payable | 15 | 39 | 31 | 34 | |||
| Deferred revenue | 0 | ✕ | ✕ | ||||
| Debt | 505 | 635 | 214 | 255 | |||
| Disposal group, including discontinued operation | 6 | ||||||
| Customer refund liability | 0 | 0 | 0 | ||||
| Other undisclosed current liabilities | 188 | 145 | 172 | ||||
| Total current liabilities: | 1,167 | 943 | 457 | 319 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 50 | 9 | |||||
| Operating lease, liability | 50 | 9 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (50) | (9) | 75 | ||||
| Total noncurrent liabilities: | 50 | 9 | 75 | ||||
| Total liabilities: | 1,217 | 952 | 457 | 394 | |||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent | 1,271 | (308) | 503 | 297 | |||
| Common stock | 3 | 1 | 1 | 39 | |||
| Additional paid in capital | 63,418 | 58,213 | 55,992 | 54,642 | |||
| Accumulated other comprehensive income | 8 | ||||||
| Accumulated deficit | (62,149) | (58,523) | (55,489) | (54,392) | |||
| Stockholders' equity attributable to noncontrolling interest | (2) | ||||||
| Total stockholders' equity: | 1,271 | (308) | 503 | 295 | |||
| TOTAL LIABILITIES AND EQUITY: | 2,489 | 643 | 961 | 689 | |||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | ||
|---|---|---|---|---|---|---|
| Revenues | 285 | 234 | 57 | 1 | ||
| Other income | 100 | |||||
| Cost of revenue | (163) | (197) | (37) | (1) | ||
| Cost of goods and services sold | (163) | (17) | ||||
| Gross profit: | 123 | 37 | 20 | 0 | ||
| Operating expenses | (3,512) | (2,076) | (1,103) | (1,973) | ||
| Operating loss: | (3,389) | (2,039) | (1,083) | (1,973) | ||
| Nonoperating income (expense) | (237) | (994) | (12) | 1,898 | ||
| Interest and debt expense | (1,093) | 113 | (138) | (292) | ||
| Loss from continuing operations before equity method investments, income taxes: | (4,720) | (2,920) | (1,233) | (366) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,093 | (113) | 138 | |||
| Loss from continuing operations: | (3,626) | (3,033) | (1,095) | (366) | ||
| Loss from discontinued operations | (2) | |||||
| Loss before gain (loss) on sale of properties: | (3,626) | (3,033) | (1,097) | (366) | ||
| Other undisclosed net income | 292 | |||||
| Net loss: | (3,626) | (3,033) | (1,097) | (75) | ||
| Net loss attributable to noncontrolling interest | (39) | |||||
| Other undisclosed net income attributable to parent | 77 | |||||
| Net loss attributable to parent: | (3,626) | (3,033) | (1,097) | (36) | ||
| Preferred stock dividends and other adjustments | (271) | |||||
| Net loss available to common stockholders, diluted: | (3,626) | (3,033) | (1,097) | (307) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | ||
|---|---|---|---|---|---|---|
| Net loss: | (3,626) | (3,033) | (1,097) | (75) | ||
| Other comprehensive income | 323 | |||||
| Comprehensive income (loss): | (3,626) | (3,033) | (1,097) | 248 | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (39) | |||||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (285) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (3,626) | (3,033) | (1,097) | (75) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.